Therapeutic potential of nanoceria pretreatment in preventing the development of urological chronic pelvic pain syndrome: Immunomodulation via reactive oxygen species scavenging and SerpinB2 downregulation

Urological chronic pelvic pain syndrome (UCPPS) manifests as pelvic pain with frequent urination and has a 10% prevalence rate without effective therapy. Nanoceria (cerium oxide nanoparticles [CNPs]) were synthesized in this study to achieve potential long‐term pain relief, using a commonly used UCP...

Descripción completa

Detalles Bibliográficos
Autores principales: Lien, Wei‐Chih, Zhou, Xin‐Ran, Liang, Ya‐Jyun, Ching, Congo Tak‐Shing, Wang, Chia‐Yih, Lu, Fu‐I, Chang, Huei‐Cih, Lin, Feng‐Huei, Wang, Hui‐Min David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842028/
https://www.ncbi.nlm.nih.gov/pubmed/36684074
http://dx.doi.org/10.1002/btm2.10346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842028/
https://www.ncbi.nlm.nih.gov/pubmed/36684074
http://dx.doi.org/10.1002/btm2.10346

Ejemplares similares